UTMD
Utah Medical Products, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-27
Figures on this page computed 2026-11-08 12:56 UTC
Last close
72.42USD
Market data, 2026-11-04
Weekly closes, 2025-11-07 to 2026-11-04
Over that span: +26.2%
Except where said otherwise: 10-K for 2025, filed 2026-03-27
20.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-27
26.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
29.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
37.2%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
0.004Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
1.7%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2026-03-27
Growth is the furthest below its sector's middle: 0.28 against 0.47 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
5 of 5 readExcept where said otherwise: 10-K for 2025, filed 2026-03-27
- Sales0.87x
Its own average over 10 years, 44.3M.
- Profit0.82x
Its own average over 10 years, 13.8M.
- Free cash flow0.84x
Its own average over 10 years, 17.0M.
- Debt1.35x
Its own average over 9 years, 377.9K.
- Price0.90x
Its own average over 11 years, 81. Market data, 2026-11-04
Debt is furthest from its own average, at 1.35 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 105.4 | 70.1 | 99.2 |
| 2018-12-31 | 106.9 | 153.0 | 99.5 |
| 2019-12-31 | 119.4 | 121.4 | 99.3 |
| 2020-12-31 | 107.3 | 89.0 | 97.5 |
| 2021-12-31 | 124.8 | 121.9 | 97.2 |
| 2022-12-31 | 133.0 | 135.8 | 96.7 |
| 2023-12-31 | 127.8 | 137.2 | 96.6 |
| 2024-12-31 | 104.1 | 114.4 | 93.0 |
| 2025-12-31 | 98.0 | 93.1 | 86.0 |
How sales was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
How profit was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
How shares in issue was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
Figures behind the shape
Growth
-1.8%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate-1.8%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Five-year EPS growth rate3.4%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
One-year change in net income-18.6%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Returns on capital
26.8%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital26.8%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
Return on equity9.5%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
Return on assets9.2%
Net Income / Total Assets x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
Margins
57.1%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin57.1%
Gross Profit / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
Operating margin29.6%
Operating Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
Net margin29.3%
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
Free cash flow margin37.2%
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
Price
20.8xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings20.8x
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-27
Price to book2.0x10-Q for 2025, filed 2026-08-12
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-001210
- Reported in
- USD
- computed
- 10-Q for 2025, filed 2026-08-12
- computed
- 10-K for 2025, filed 2026-03-27
EV to EBITDA12.2x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
- 10-K for 2025, filed 2026-03-27
Price to sales ratio6.1x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
Safety
0.004safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity0.004
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
Current ratio37.6210-Q for 2025, filed 2026-08-12
Current Assets / Current Liabilities
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-001210
- Reported in
- USD
- 10-Q for 2025, filed 2026-08-12
- 10-Q for 2025, filed 2026-08-12
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
Altman Z-Score45.91
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- Computed from the 10-K for 2025, filed 2026-03-27
- Computed from the 10-K for 2025, filed 2026-03-27
- Computed from the 10-K for 2025, filed 2026-03-27
- Computed from the 10-K for 2025, filed 2026-03-27
- Computed from the 10-K for 2025, filed 2026-03-27
What it pays out
1.7%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield1.7%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2026-03-27
Payout ratio35.3%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- Computed from the 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
Dividend cover ratio3.6x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.